Back

Dual versus single antiplatelet therapy after coronary artery bypass grafting: a meta-analysis of randomized controlled trials

28 August 2026 (14:15 - 15:00)
Organised by: Logo
Congress Presentation Part of: Pharmacotherapy and revascularisation: parallel ways to treat patients with chronic coronary syndromes Pharmacotherapy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Taizo Yoshida

Montefiore Medical Center Albert Einstein College of Medicine, New York (United States of America)

4 More presentations in this session

Presentation thumbnail
Comparative efficacy of clopidogrel and aspirin monotherapy after dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis
Doctor N. Ktenopoulos (Athens, GR)
Abstract Slides Video
Presentation thumbnail
Clopidogrel or prasugrel vs. aspirin monotherapy for long-term secondary prevention after percutaneous coronary intervention for acute coronary syndrome
Doctor Y. Iwanaga (Suita, JP)
Abstract Slides Video
Presentation thumbnail
The role of ranolazine in managing chronic coronary syndrome: a synthesis of clinical outcomes and health economic modelling
Doctor I. Alhaddad (Amman, JO)
Abstract Slides Video
Presentation thumbnail
Efficacy and safety of antithrombotic strategies for atrial fibrillation in patients with chronic coronary syndrome according to coronary treatment strategy: a meta-analysis of randomized trials
Professor Y. Jeong (Gwangmyeong, KR)
Abstract Slides Video

Access the full session

Session thumbnail
Pharmacotherapy and revascularisation: parallel ways to treat patients with chronic coronary syndromes

The Event

Event poster

ESC Congress 2026

28 August 2026 14:15 CET
You may be interested in
thumbnail
Congress Presentation
Antiplatelet strategies in acute myocardial infarction undergoing coronary artery bypass grafting
20 March 2026
thumbnail
Congress Presentation
Comparative effects of different antiplatelet strategies in carriers of CYP2C19 loss-of-function alleles: a network meta-analysis
1 September 2024
thumbnail
Congress Presentation
Influence of baseline Hb1Ac and antiplatelet therapy on 5-year clinical outcomes after coronary artery bypass grafting.
30 August 2025
thumbnail
Congress Presentation
Anticoagulation strategy of choice for atrial fibrillation ablation - a network meta-analysis of complication rates
30 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources